Press releases

  • Tuesday, 25 November 2014

    New data from a pooled analysis shows improved overall survival for prostate cancer patients treated with FIRMAGON® (degarelix) compared to LHRH agonists

    Read press release
  • Monday, 20 October 2014

    CORTIMENT®MMX®, a new treatment for ulcerative colitis, receives European approval

    Read press release
  • Monday, 13 October 2014

    The Scottish Medicines Consortium (SMC) accepts MYSODELLE® for use in NHS Scotland

    Read press release
  • Tuesday, 24 June 2014

    Ferring Pharmaceuticals and Roche collaborate to develop personalised infertility treatment

    Read press release
Archive:

Helen Gallagher

Senior Director
Corporate Communications
Tel: +41 58 301 00 51

Patrick Gorman

Associate Director
Corporate Communications
Tel: +41 58 301 00 53

Corporate Communications

Ferring International Center S.A.
Ch. de la Vergognausaz 50
CH-1162 Saint-Prex
Switzerland
Tel: +41 58 301 00 00
Fax: +41 58 301 00 10
email

Headquarters

Ferring International Center S.A.
Ch. de la Vergognausaz 50
1162 Saint-Prex
Switzerland

Tel:  +41 58 301 00 00
Fax: +41 58 301 00 10

Contact

GLOBAL LOCATOR